The deal, focused on strengthening primary healthcare systems, disease surveillance, and community-level medical access, comes amid intensifying competition for influence in the Sahel, where shifting alliances and security realignments have reshaped regional dynamics.
The U.S. Department of State will provide up to $147 million over five years to help Burkina Faso fight HIV/AIDS, malaria, and other infectious diseases, while improving disease surveillance and outbreak response.
Burkina Faso will contribute $107 million to its health system, with an additional $12 million earmarked to strengthen community health, digitize reporting, and expand lab capacity.
The deal, concluded with Burkina Faso’s military-led government, signals a notable recalibration in Washington’s engagement with a region that has, in recent years, steadily drifted away from Western security partnerships.
At a time when military juntas in the Sahel have expelled French forces and deepened ties with Russia, Washington appears to be reasserting its presence through health diplomacy which is a softer but strategically significant instrument of influence.
Health diplomacy or geopolitical recalibration?
While there is no official clause tying health funding to mineral access or military basing rights, geopolitical logic suggests Washington is keen to prevent further erosion of influence in a region where Russia and China are expanding their footprint.
Health security also aligns with domestic U.S. priorities: preventing cross-border pandemics, stabilising fragile states to reduce migration pressures, and maintaining diplomatic channels with governments that may otherwise drift toward rival powers.
Some African Governments Push Back on U.S. Health Deal
While Washington has secured a series of new health financing agreements across Africa, not all governments have embraced the model without hesitation.
Zimbabwe became the most prominent case of outright withdrawal after stepping away from negotiations over a proposed U.S.-backed health funding package reportedly valued in the hundreds of millions of dollars. Harare cited sovereignty concerns, particularly around provisions linked to data governance and oversight structures embedded in the framework.
Does the United States expect anything in return? Officially, no. The agreements are framed as partnerships for mutual health security.
Unofficially, the returns are strategic: sustained diplomatic presence, improved intelligence cooperation through public health systems, leverage in multilateral forums, and indirect positioning in mineral-rich regions.
The U.S. State Department has finalized 17 bilateral global health memoranda of understanding with countries such as Botswana, Burkina Faso, Burundi, Cameroon, Côte d’Ivoire, Eswatini, Ethiopia, Kenya, Lesotho, Liberia, Madagascar, Malawi, Mozambique, Nigeria, Rwanda, Sierra Leone, and Uganda, as of February 25.
In an era of intensifying great-power competition, America’s health deals in Africa are not merely about clinics and vaccines. They are about influence and the Sahel has become the latest proving ground.
